Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitals
Author(s) -
Franziska Layer,
Sophia Vourli,
Vasilios Karavasilis,
Birgit Strommenger,
Konstantina Dafopoulou,
Athanassios Tsakris,
Guido Werner,
Spyros Pournaras
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx524
Subject(s) - linezolid , etest , staphylococcus epidermidis , microbiology and biotechnology , multilocus sequence typing , broth microdilution , staphylococcus aureus , methicillin resistant staphylococcus aureus , sccmec , biology , medicine , antibiotics , vancomycin , genetics , bacteria , gene , genotype , minimum inhibitory concentration
Linezolid-resistant Staphylococcus epidermidis (LRSE) and linezolid-dependent ST22 strains have been shown to predominate in tertiary care facilities all over Greece. We report herein the dissemination of ST22 but also ST2, ST5 and ST168 linezolid-dependent LRSE clones in four unrelated German hospitals.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom